Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Vitrectomy Combined with Intraoperative Dexamethasone Implant for the Management of Refractory Diabetic Macular Edema.

Kim KT, Jang JW, Kang SW, Chae JB, Cho K, Bae K.

Korean J Ophthalmol. 2019 Jun;33(3):249-258. doi: 10.3341/kjo.2018.0100.

2.

Efficacy of vitrectomy combined with an intraoperative dexamethasone implant in refractory diabetic macular edema.

Jung YH, Lee Y.

Acta Diabetol. 2019 Jun;56(6):691-696. doi: 10.1007/s00592-019-01305-w. Epub 2019 Mar 1.

PMID:
30824977
3.

Vitrectomy combined with intravitreal triamcinolone acetonide injection and macular laser photocoagulation for nontractional diabetic macular edema.

Kim JH, Kang SW, Ha HS, Kim JR.

Korean J Ophthalmol. 2013 Jun;27(3):186-93. doi: 10.3341/kjo.2013.27.3.186. Epub 2013 Apr 25.

4.

VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING FOR TRACTIONAL AND NONTRACTIONAL DIABETIC MACULAR EDEMA: Long-term Results of a Comparative Study.

Bonnin S, Sandali O, Bonnel S, Monin C, El Sanharawi M.

Retina. 2015 May;35(5):921-8. doi: 10.1097/IAE.0000000000000433.

PMID:
25545486
5.

Minimally Invasive Microincision Vitrectomy Surgery with an Intraoperative Dexamethasone Implant for Refractory Diabetic Macular Edema.

Lee DH, Kim YJ, Yoon YH.

Ophthalmologica. 2016;235(3):150-6. doi: 10.1159/000443751. Epub 2016 Feb 24.

PMID:
26908130
6.

Combination of vitrectomy, IVTA, and laser photocoagulation for diabetic macular edema unresponsive to prior treatments; 3-year results.

Kim YT, Kang SW, Kim SJ, Kim SM, Chung SE.

Graefes Arch Clin Exp Ophthalmol. 2012 May;250(5):679-84. doi: 10.1007/s00417-011-1888-1. Epub 2011 Dec 10.

PMID:
22160508
7.

Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema.

Pessoa B, Coelho J, Correia N, Ferreira N, Beirão M, Meireles A.

Ophthalmic Res. 2018;59(2):68-75. doi: 10.1159/000484091. Epub 2017 Dec 16.

8.

Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.

Kang SW, Park SC, Cho HY, Kang JH.

Am J Ophthalmol. 2007 Dec;144(6):878-885. Epub 2007 Oct 15.

PMID:
17936715
9.

Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.

Sze AM, Luk FO, Yip TP, Lee GK, Chan CK.

Eur J Ophthalmol. 2015 Mar-Apr;25(2):168-72. doi: 10.5301/ejo.5000523. Epub 2014 Oct 21.

PMID:
25363857
10.

Dexamethasone intravitreal implant in vitrectomized versus nonvitrectomized eyes for treatment of patients with persistent diabetic macular edema.

Medeiros MD, Alkabes M, Navarro R, Garcia-Arumí J, Mateo C, Corcóstegui B.

J Ocul Pharmacol Ther. 2014 Nov;30(9):709-16. doi: 10.1089/jop.2014.0010. Epub 2014 Sep 26.

PMID:
25259834
11.

Outcomes of vitrectomy, membranectomy and internal limiting membrane peeling in patients with refractory diabetic macular edema and non-tractional epiretinal membrane.

Ghassemi F, Bazvand F, Roohipoor R, Yaseri M, Hassanpoor N, Zarei M.

J Curr Ophthalmol. 2016 Aug 27;28(4):199-205. eCollection 2016 Dec.

12.

Efficacy of dexamethasone intravitreal implant for the treatment of persistent diffuse diabetic macular edema.

Esen E, Sizmaz S, Demircan N.

Int Ophthalmol. 2017 Feb;37(1):1-6. doi: 10.1007/s10792-016-0219-2. Epub 2016 Mar 11.

PMID:
26968412
13.
14.

Macular ischemia and outcome of vitrectomy for diabetic macular edema.

Kim J, Kang SW, Shin DH, Kim SJ, Cho GE.

Jpn J Ophthalmol. 2015 Sep;59(5):295-304. doi: 10.1007/s10384-015-0402-4. Epub 2015 Aug 1.

PMID:
26227834
15.

ILM peeling in nontractional diabetic macular edema: review and metanalysis.

Rinaldi M, dell'Omo R, Morescalchi F, Semeraro F, Gambicorti E, Cacciatore F, Chiosi F, Costagliola C.

Int Ophthalmol. 2018 Dec;38(6):2709-2714. doi: 10.1007/s10792-017-0761-6. Epub 2017 Oct 31. Review.

PMID:
29090356
16.

Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.

Castro-Navarro V, Cervera-Taulet E, Navarro-Palop C, Monferrer-Adsuara C, Hernández-Bel L, Montero-Hernández J.

BMC Ophthalmol. 2019 Jan 11;19(1):15. doi: 10.1186/s12886-018-1022-9.

17.

Pars plana vitrectomy versus three intravitreal injections of bevacizumab for nontractional diabetic macular edema. A prospective, randomized comparative study.

Raizada S, Al Kandari J, Al Diab F, Al Sabah K, Kumar N, Mathew S.

Indian J Ophthalmol. 2015 Jun;63(6):504-10. doi: 10.4103/0301-4738.162602.

18.

Comparative study of vitrectomy versus intravitreous triamcinolone for diabetic macular edema on randomized paired-eyes.

Doi N, Sakamoto T, Sonoda Y, Yasuda M, Yonemoto K, Arimura N, Uchino E, Ishibashi T.

Graefes Arch Clin Exp Ophthalmol. 2012 Jan;250(1):71-8. doi: 10.1007/s00417-011-1777-7. Epub 2011 Aug 19.

PMID:
21853229
19.

Comparison of early dexamethasone retreatment versus standard dexamethasone regimen combined with PRN ranibizumab in diabetic macular edema.

Arıkan Yorgun M, Toklu Y, Mutlu M.

Int Ophthalmol. 2017 Feb;37(1):185-196. doi: 10.1007/s10792-016-0251-2. Epub 2016 May 12.

PMID:
27173834
20.

Intravitreal dexamethasone implants for diabetic macular edema.

Pareja-Ríos A, Ruiz-de la Fuente-Rodríguez P, Bonaque-González S, López-Gálvez M, Lozano-López V, Romero-Aroca P.

Int J Ophthalmol. 2018 Jan 18;11(1):77-82. doi: 10.18240/ijo.2018.01.14. eCollection 2018.

Supplemental Content

Support Center